Stocks and Investing Stocks and Investing
Thu, May 23, 2024
Wed, May 22, 2024
Tue, May 21, 2024

Anupam Rama Maintained (SNDX) at Buy and Held Target at $34 on, May 21st, 2024


Published on 2024-10-28 11:29:53 - WOPRAI
  Print publication without navigation


Anupam Rama of JP Morgan, Maintained "Syndax Pharmaceuticals, Inc." (SNDX) at Buy and Held Target at $34 on, May 21st, 2024.

Anupam has made no other calls on SNDX in the last 4 months.



There are 4 other peers that have a rating on SNDX. Out of the 4 peers that are also analyzing SNDX, 1 agrees with Anupam's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • George Farmer of "Scotiabank" Downgraded from Buy to Hold and Decreased Target to $23 on, Wednesday, January 31st, 2024


These are the ratings of the 3 analyists that currently disagree with Anupam


  • Bradley Canino of "Stifel" Maintained at Strong Buy with Increased Target to $40 on, Thursday, May 9th, 2024
  • Edward White of "HC Wainwright & Co." Reiterated at Strong Buy and Held Target at $41 on, Thursday, May 9th, 2024
  • Yigal Nochomovitz of "Citigroup" Maintained at Strong Buy with Decreased Target to $30 on, Thursday, May 9th, 2024